Microbot Medical Inc. Files 8-K

Ticker: MBOT · Form: 8-K · Filed: Sep 30, 2024 · CIK: 883975

Microbot Medical Inc. 8-K Filing Summary
FieldDetail
CompanyMicrobot Medical Inc. (MBOT)
Form Type8-K
Filed DateSep 30, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, corporate-filing

TL;DR

Microbot Medical filed an 8-K on 9/30/24 - check for updates.

AI Summary

Microbot Medical Inc. filed an 8-K on September 30, 2024, reporting on events including Regulation FD disclosures, other events, and financial statements. The company, formerly known as STEMCELLS INC and CYTOTHERAPEUTICS INC/DE, is incorporated in Delaware and based in Braintree, MA.

Why It Matters

This filing provides important updates and disclosures for investors regarding Microbot Medical Inc.'s corporate activities and financial status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains standard corporate disclosures and does not inherently signal significant new risks.

Key Players & Entities

  • Microbot Medical Inc. (company) — Registrant
  • STEMCELLS INC (company) — Former Company Name
  • CYTOTHERAPEUTICS INC/DE (company) — Former Company Name
  • September 30, 2024 (date) — Date of earliest event reported

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves to report on Regulation FD disclosures, other events, and financial statements of Microbot Medical Inc.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on September 30, 2024.

What are the former names of Microbot Medical Inc. mentioned in the filing?

The filing mentions that Microbot Medical Inc. was formerly known as STEMCELLS INC and CYTOTHERAPEUTICS INC/DE.

In which state is Microbot Medical Inc. incorporated?

Microbot Medical Inc. is incorporated in Delaware.

What is the principal executive office address for Microbot Medical Inc.?

The principal executive offices are located at 288 Grove Street, Suite 388, Braintree, MA 02184.

Filing Stats: 940 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2024-09-30 08:33:51

Key Financial Figures

  • $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: September 30, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.